Multi-Omics and Machine Learning Analyses Reveal PIK3CG, PRKCD, and TRIM22 as Potential Markers of Poor Prognosis and Immune Activation in Glioblastoma.

J Korean Med Sci · 2026 · PMC13120869 · PMID 42046521

Europe PMC DOI

hedged sentence

0.0820

closest p · 1.6× alpha

0.0820

boldest claim

The sentences

showed a trendP = 0.082so close (0.05 < p ≤ 0.1)

High expression of PIK3CG, PRKCD, and TRIM22 showed a trend toward increased CD274 (PD-L1-encoding gene) expression ( P = 0.082, 0.012, and 0.090, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.